Schonfeld Strategic Advisors LLC
Position in UTHR — UNITED THERAPEUTICS Corp
CIK 1665241
NEW YORK, NY
Position in UTHR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,543,884
-$8,223,853 QoQ
Shares Held
4,290
-80.6% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Schonfeld Strategic Advisors LLC holds $50,240,980 across 18 Drug Manufacturers - Specialty & Generic names. UTHR ranks #4 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ANIP |
Ani Pharmaceuticals Inc
|
185,629 | $14,274,870 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,337,693 | $12,734,837 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
56,615 | $7,458,460 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
4,290 | $2,543,884 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
48,765 | $2,520,662 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
43,599 | $2,099,291 | |
| 7 | ZTS |
Zoetis Inc.
|
16,271 | $1,923,394 | |
| 8 | XERS |
Xeris Biopharma Holdings, Inc.
|
296,431 | $1,719,299 |
All Filings in UTHR
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,543,884 | 4,290 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,767,737 | 22,099 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $45,673,348 | 108,951 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $712,628 | 2,480 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $612,224 | 1,986 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,552,496 | 4,400 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,197,760 | 6,133 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,537,283 | 20,522 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $19,669,315 | 85,623 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $18,601,594 | 84,595 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $11,083,892 | 49,072 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $8,697,550 | 39,400 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,114,985 | 31,769 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $22,363,441 | 80,418 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,365,990 | 25,628 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,556,211 | 27,823 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $340,879 | 1,900 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,852,256 | 13,200 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $4,730,785 | 25,630 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $663,817 | 3,700 | Shares | Sole | 2021-11-16 | |
| 2021-03-31 | $2,258,145 | 13,500 | Shares | Sole | 2021-05-17 | |
| 2020-06-30 | $262,691 | 2,171 | Shares | Sole | 2020-09-15 | |
| 2020-03-31 | $614,213 | 6,477 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||